Editors Paul Schrimpf and Eric Sfiligoj discuss the upcoming CES Show in Las Vegas, the U.S. government stepping […]
Two different agencies call for appeals court to reverse lower court decision against herbicide.
While most of agriculture in 2019 was engaged in playing a form of survivor, perhaps the ultimate example […]
Next year could be a pivotal one for the popular herbicide.
Editor Eric Sfiligoj recounts the Environmental Respect Awards event last week and weighs in on glyphosate lawsuit news. […]
Recently, I devoted an entire column to the fact that science was finally coming back to the forefront […]
CropLife Editors Paul Schrimpf and Eric Sfiligoj discuss market updates from the 2019 Mid America CropLife Association meeting, […]
Recently, while I was attending the AgriBusiness GlobalSM Trade Summit, one of the major topics of conversation was […]
As a country, Germany has a great reputation in science and scientific endeavors. In fact, the Nobel Prize […]
Editors Paul Schrimpf and Eric Sfiligoj share thoughts on EPA’s rebuff of California glyphosate labeling, tough news for […]
For several years now, glyphosate has been taking a very public beating regarding its safety in the courtrooms […]
Paul Schrimpf joins Eric Sfiligoj trade experiences from the 2019 InfoAg Conference and ABG Trade Summit, and have […]
A Bloomberg News story reported this morning that Bayer is proposing to pay as much as $8 billion to […]
Finally, there is a small bit of good news for the crop protection marketplace from the courtrooms of […]
Editors Paul Schrimpf and Eric Sfiligoj discuss Paul’s trip through Pennsylvania, the return of a popular insecticide, and […]
Editors Paul Schrimpf and Eric Sfiligoj discuss the proposed countrywide glyphosate ban in Austria, Thurston Manufacturing’s Blu-Jet sale, […]
Glyphosate may have the majority of scientific evidence behind its safety record, but governmental support in some countries […]
Editors Paul Schrimpf and Eric Sfiligoj discuss the recent 4R Summit in Cleveland, state plantings updates, and more […]
Another glyphosate-cancer trial in California has ended, with a jury awarding more than $2 billion to an elderly […]